Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...

The US Securities and Exchange Commission (SEC) adopted amendments to Regulation National Market System (Regulation NMS or Reg NMS). Regulation NMS was adopted in 2005 to provide a comprehensive ...

While I fully supported then, as I do now, the worthy goal of enhancing market efficiency, then-Commissioner Cynthia Glassman ...

WE REPORT A CASE INVOLVING AN 81-YEAR-OLD man with schizoaffective disorder who presented with neuroleptic malignant syndrome (NMS) after an increase in his neuroleptic dose. NMS, a rare but ...

HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the appointment of Tatyana Kosheleva as Chief Financial Officer, ...

As we recently discussed, the SEC has a number of significant rule change proposals on the slate right now. One of those proposals involves splitting the old National Best Bid and Offer (NBBO) into ...

HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs announced today that David Delia has been selected as the new President and Chief Executive Officer of the Company. Mr. Delia will guide the organization’s ...

Counseling Department hosted its annual Career Day on Friday, December 5. A long-standing tradition at NMS since 2002, Career ...